HC Wainwright Forecasts Higher Earnings for UroGen Pharma
UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – HC Wainwright lifted their Q2 2025 earnings estimates for UroGen Pharma in a note issued to investors on Tuesday, May 13th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.75) for the quarter, up from their prior estimate of […]
UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) – HC Wainwright lifted their Q2 2025 earnings estimates for UroGen Pharma in a note issued to investors on Tuesday, May 13th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.75) for the quarter, up from their prior estimate of […]
